Minimal Benzodiazepine Exposure May Up Dementia Risk

Share this content:
Minimal Benzodiazepine Exposure May Up Dementia Risk
Minimal Benzodiazepine Exposure May Up Dementia Risk

THURSDAY, Feb. 4, 2016 (HealthDay News) -- Patients with minimal exposure to benzodiazepine have a slightly increased risk of dementia, according to a study published online Feb. 2 in The BMJ.

Shelly L. Gray, Pharm.D., from the University of Washington in Seattle, and colleagues conducted a prospective population-based cohort study involving 3,434 participants aged 65 years and older without dementia at study entry. The authors administered the cognitive screening instrument every two years to screen for dementia and assess cognitive trajectory. Computerized pharmacy data were used to identify benzodiazepine exposure, which consisted of the total standardized daily doses (TSDDs) dispensed over a 10-year period.

The researchers found that 23.2 percent of participants (797 participants) developed dementia over a mean follow-up of 7.3 years, of whom 637 developed Alzheimer's disease. For cumulative benzodiazepine use of one to 30, 31 to 120, and ≥121 TSDDs versus non-use, the hazard ratios for dementia were 1.25 (95 percent confidence interval [CI], 1.03 to 1.51), 1.31 (95 percent CI, 1.00 to 1.71), and 1.07 (95 percent CI, 0.82 to 1.39), respectively. Similar results were seen for Alzheimer's disease. There was no correlation for higher benzodiazepine use with more rapid cognitive decline.

"The risk of dementia is slightly higher in people with minimal exposure to benzodiazepines but not with the highest level of exposure," the authors write. "These results do not support a causal association between benzodiazepine use and dementia."

One author disclosed financial ties to UpToDate; one author disclosed financial ties to the pharmaceutical industry.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NIH Panel Will No Longer Review Gene Therapy Experiments

NIH Panel Will No Longer Review Gene Therapy ...

FDA will now assess gene therapy experiments and products as it does with other treatments, drugs

Doctors Remove Contact Lens Embedded in Eyelid for Years

Doctors Remove Contact Lens Embedded in Eyelid for ...

Lens was encapsulated within the upper eyelid soft tissue since childhood eye trauma

CDC: Brucellosis in Dogs Remains a Public Health Risk

CDC: Brucellosis in Dogs Remains a Public Health ...

Infection is under-recognized, may remain a threat without stronger intervention measures

is free, fast, and customized just for you!




Already a member?

Sign In Now »